Bradley, Margaret External Entity

Publications

Sort by

Selected publications

  • Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.  The oncologist. 2017 In Process GET IT

Other